Skye Bioscience, Inc. Capital Expenditures
Skye Bioscience, Inc. (SKYE) reported Capital Expenditures of $0 for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquirePropertyPlantAndEquipment · last filed 2026-08-14
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-06-30 was $0.00.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for the quarter ending 2026-03-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-12-31 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for fiscal 2025 was $6.31K, a 99.61% decline from fiscal 2024.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for fiscal 2024 was $1.60M, a 12681.09% increase from fiscal 2023.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for fiscal 2023 was $12.55K, a 55.27% decline from fiscal 2022.
- Skye Bioscience, Inc. payments to acquire property, plant, and equipment for fiscal 2022 was $28.06K, a 69.12% decline from fiscal 2021.
| Period end | Payments to Acquire Property, Plant, and Equipment 3 month | Payments to Acquire Property, Plant, and Equipment 6 month | Payments to Acquire Property, Plant, and Equipment 6 month as first filed | Payments to Acquire Property, Plant, and Equipment 9 month | Payments to Acquire Property, Plant, and Equipment 9 month as first filed | Payments to Acquire Property, Plant, and Equipment 12 month | Payments to Acquire Property, Plant, and Equipment 25 month | Payments to Acquire Property, Plant, and Equipment 29 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $0.00 10-Q · filed 2026-08-14 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2026-03-31 | $0.00 10-Q · filed 2026-05-11 | $0.00 derived: sum of 2 quarters · filed 2026-05-11 | $0.00 derived: sum of 3 quarters · filed 2026-05-11 | $0.00 derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $0.00 derived: sum of 2 quarters · filed 2026-03-10 | $0.00 derived: sum of 3 quarters · filed 2026-08-14 | $6.31K 10-K · filed 2026-03-10 | ||||
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $0.00 derived: sum of 2 quarters · filed 2026-08-14 | $6.31K 10-Q · filed 2025-11-10 | $56.34K derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-14 | $6.31K 10-Q · filed 2026-08-14 | $56.34K derived: sum of 3 quarters · filed 2026-08-14 | $1.57M derived: sum of 4 quarters · filed 2026-08-14 | ||||
| 2025-03-31 | $6.31K 10-Q · filed 2026-05-11 | $56.34K derived: sum of 2 quarters · filed 2026-05-11 | $1.57M derived: sum of 3 quarters · filed 2026-05-11 | $1.61M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $50.02K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $1.57M derived: sum of 2 quarters · filed 2026-03-10 | $1.60M derived: sum of 3 quarters · filed 2026-03-10 | $1.60M 10-K · filed 2026-03-10 | ||||
| 2024-09-30 | $1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $1.55M derived: sum of 2 quarters · filed 2025-11-10 | $1.55M 10-Q · filed 2025-11-10 | $1.56M derived: sum of 4 quarters · filed 2025-11-10 | ||||
| 2024-06-30 | $32.46K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $35.64K 10-Q · filed 2025-08-07 | $42.66K derived: sum of 3 quarters · filed 2025-08-07 | $46.33K derived: sum of 4 quarters · filed 2025-08-07 | ||||
| 2024-03-31 | $3.18K 10-Q · filed 2025-05-08 | $10.20K derived: sum of 2 quarters · filed 2025-05-08 | $13.87K derived: sum of 3 quarters · filed 2025-05-08 | $13.87K derived: sum of 4 quarters · filed 2025-05-08 | ||||
| 2023-12-31 | $7.02K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $10.69K derived: sum of 2 quarters · filed 2025-03-20 | $10.69K derived: sum of 3 quarters · filed 2025-03-20 | $12.55K 10-K · filed 2025-03-20 | ||||
| 2023-09-30 | $3.67K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-07 | $3.67K derived: sum of 2 quarters · filed 2024-11-07 | $5.53K 10-Q · filed 2024-11-07 | $18.04K derived: sum of 4 quarters · filed 2024-11-07 | ||||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $1.86K 10-Q · filed 2024-08-09 | $14.36K derived: sum of 3 quarters · filed 2024-08-09 | $24.71K derived: sum of 4 quarters · filed 2024-08-09 | ||||
| 2023-03-31 | $1.86K 10-Q · filed 2024-05-10 | $14.36K derived: sum of 2 quarters · filed 2024-05-10 | $24.71K derived: sum of 3 quarters · filed 2024-05-10 | $27.92K derived: sum of 4 quarters · filed 2024-05-10 | ||||
| 2022-12-31 | $12.50K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-22 | $22.85K derived: sum of 2 quarters · filed 2024-03-22 | $26.06K derived: sum of 3 quarters · filed 2024-03-22 | $28.06K 10-K · filed 2024-03-22 | ||||
| 2022-09-30 | $10.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14 | $13.56K derived: sum of 2 quarters · filed 2023-11-14 | $15.56K 10-Q · filed 2023-11-14 | $69.59K derived: sum of 4 quarters · filed 2023-11-14 | ||||
| 2022-06-30 | $3.21K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | $5.21K 10-Q · filed 2023-08-07 | $59.25K derived: sum of 3 quarters · filed 2023-08-07 | $85.91K derived: sum of 4 quarters · filed 2023-08-07 | ||||
| 2022-03-31 | $2.00K 10-Q · filed 2023-05-12 | $56.04K derived: sum of 2 quarters · filed 2023-05-12 | $82.69K derived: sum of 3 quarters · filed 2023-05-12 | $82.17K derived: sum of 4 quarters · filed 2023-05-12 | ||||
| 2021-12-31 | $54.04K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $80.70K derived: sum of 2 quarters · filed 2023-03-31 | $80.17K derived: sum of 3 quarters · filed 2023-03-31 | $90.87K 10-K · filed 2023-03-31 | ||||
| 2021-09-30 | $26.66K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $26.13K derived: sum of 2 quarters · filed 2022-11-14 | $36.83K 10-Q · filed 2022-11-14 | $44.06K derived: sum of 4 quarters · filed 2022-11-14 | ||||
| 2021-06-30 | -$526.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-15 | $10.17K 10-Q · filed 2022-08-15 | $17.40K derived: sum of 3 quarters · filed 2022-08-15 | $17.40K derived: sum of 4 quarters · filed 2022-08-15 | ||||
| 2021-03-31 | $10.70K 10-Q · filed 2022-05-06 | $17.93K derived: sum of 2 quarters · filed 2022-05-06 | $17.93K derived: sum of 3 quarters · filed 2022-05-06 | $17.93K derived: sum of 4 quarters · filed 2022-05-06 | ||||
| 2020-12-31 | $7.23K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-28 | $7.23K derived: sum of 2 quarters · filed 2022-03-28 | $7.23K derived: sum of 3 quarters · filed 2022-03-28 | $7.23K 10-K · filed 2022-03-28 | ||||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | $0.00 derived: sum of 2 quarters · filed 2021-11-10 | $0.00 10-Q · filed 2021-11-10 | |||||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $0.00 10-Q · filed 2021-08-06 | ||||||
| 2020-03-31 | $0.00 10-Q · filed 2021-05-07 | |||||||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-23 | $0.00 derived: sum of 2 quarters · filed 2020-03-23 | $3.33K derived: sum of 3 quarters · filed 2020-03-23 | $4.38K 10-K · filed 2020-03-23 | ||||
| 2018-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | $3.33K derived: sum of 2 quarters · filed 2019-11-14 | $4.38K 10-Q · filed 2019-11-14 | |||||
| 2018-06-30 | $3.33K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | $4.38K 10-Q · filed 2019-08-09 | ||||||
| 2018-03-31 | $1.06K 10-Q · filed 2019-05-10 | |||||||
| 2017-12-31 | $19.65K 10-K · filed 2019-03-14 | |||||||
| 2016-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-19 | $1.00 derived: sum of 2 quarters · filed 2018-03-19 | $1.00 derived: sum of 3 quarters · filed 2018-03-19 | $11.12K 10-K · filed 2018-03-19 | ||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-14 | $0.00 derived: sum of 2 quarters · filed 2017-11-14 | $11.12K 10-Q · filed 2017-11-14 | $11.12K derived: sum of 4 quarters · filed 2017-11-14 | ||||
| 2016-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-11 | $11.12K 10-Q · filed 2017-08-11 | $11.12K derived: sum of 3 quarters · filed 2017-08-11 | |||||
| 2016-03-31 | $11.12K 10-Q · filed 2017-05-12 | $11.12K derived: sum of 2 quarters · filed 2017-05-12 | ||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-10 | $1.98K 10-K · filed 2017-03-10 | ||||||
| 2015-09-30 | $1.98K 10-Q · filed 2016-11-09 | |||||||
| 2014-12-31 | $10.87K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-21 | $23.26K 10-K · filed 2016-03-21 | ||||||
| 2014-09-30 | $12.39K 10-Q · filed 2015-11-12 | |||||||
| 2014-07-31 | $67.83K 10-Q · filed 2014-09-15 | |||||||
| 2013-10-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-01-27 | $0.00 derived: sum of 2 quarters · filed 2014-09-15 | $1.65K derived: sum of 3 quarters · filed 2014-09-15 | $49.12K 10-K · filed 2014-01-27 | ||||
| 2013-07-31 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-09-15 | $1.65K derived: sum of 2 quarters · filed 2014-09-15 | $49.12K 10-Q · filed 2014-09-15 | $74.12K 10-Q · filed 2013-09-16 | $74.12K 10-Q · filed 2013-09-16 | |||
| 2013-04-30 | $1.65K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-06-05 | $49.12K 10-Q · filed 2014-06-05 | $74.12K 10-Q · filed 2013-06-27 | $74.12K 10-Q · filed 2013-06-27 | ||||
| 2013-01-31 | $47.47K 10-Q · filed 2014-03-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |